Biogen (BIIB)
(Delayed Data from NSDQ)
$208.90 USD
+6.44 (3.18%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $208.23 -0.67 (-0.32%) 6:56 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/23/2024
Time: -- |
6/2024 | $3.97 | 0.97% |
Earnings Summary
For their last quarter, Biogen (BIIB) reported earnings of $3.67 per share, beating the Zacks Consensus Estimate of $3.45 per share. This reflects a positive earnings surprise of 6.38%. Look out for BIIB's next earnings release expected on July 23, 2024. For the next earning release, we expect the company to report earnings of $3.97 per share, reflecting a year-over-year decrease of 1.24%.
Earnings History
Price & Consensus
Zacks News for BIIB
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
BIIB: What are Zacks experts saying now?
Zacks Private Portfolio Services